Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Aug 4;12(8):1887.
doi: 10.3390/diagnostics12081887.

A Unique Observation of a Patient with Vulto-van Silfhout-de Vries Syndrome

Affiliations
Case Reports

A Unique Observation of a Patient with Vulto-van Silfhout-de Vries Syndrome

Natalia Bodunova et al. Diagnostics (Basel). .

Abstract

Introduction: Vulto-van Silfhout-de Vries Syndrome (VSVS; OMIM#615828) is a rare hereditary disease associated with impaired intellectual development and speech, delayed psychomotor development, and behavioral anomalies, including autistic behavioral traits and poor eye contact. To date, 27 patients with VSVS have been reported in the literature. Materials and Methods: We describe a 23-year-old male patient with autism spectrum disorder (ASD) who was admitted to the gastroenterological hospital with signs of pseudomembranous colitis. ASD was first noted in the patient at the age of 2.5 years. Later, he developed epileptic seizures and important growth retardation. Prior to the hospitalization, chromosomal aberrations, Fragile X syndrome, and aminoacidopathies/aminoacidurias associated with ASD were excluded. Whole-genome sequencing (WGS) was prescribed to the patient at 23 years old. Results: The patient had a heterozygous carrier of “de novo” variant c.662C > T (p.S221L) in exon 4 of the DEAF1 gene. c.662C > T had not been previously described in genomic databases. According to the ACMG criteria, this missense variant was considered to be pathogenic. VSVS was diagnosed in the patient. Conclusions: The phenotype of the patient is very similar to the data presented in the world literature. However, growth retardation and cachexia, which have not been described previously in the articles, are of interest.

Keywords: DEAF1; VSVS; VULTO-VAN syndrome.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The structure of the DEAF1 gene and the spectrum of gene variants detected earlier in patients with VSVS. * Termination of protein synthesis.
Figure 2
Figure 2
Phenotype of the patient with Vulto-Van Silfhout-De Vries Syndrome at different ages. (A) Patient at 5 months of age; (B) patient at 10 months of age; (C) patient at 4 years old; (D) patient at 6 years old, (E) patient at 23 years old, (F) dermatoglyphics of the palms of the patient at 23 years old.
Figure 3
Figure 3
Pedigree of the patient with Vulto-Van Silfhout-De Vries Syndrome.
Figure 4
Figure 4
Electrophoregram of the nucleotide sequence of the DEAF1 gene. (A) Substitution c.662C > T in the heterozygous state in the proband (indicated by the arrow). (B) The wild-type genotype at position c.662 in the sister, mother, and father of the proband (indicated by the arrow).

Similar articles

Cited by

References

    1. Cheng P.J., Chueh H.Y., Shaw S.W., Hsu J.J., Hsieh T.T., Soong Y.K. X Pentasomy in an Intracytoplasmic Sperm Injection Pregnancy Detected by Nuchal Translucency Testing. Fetal Diagn. Ther. 2008;24:299–303. doi: 10.1159/000158653. - DOI - PubMed
    1. Vulto-van Silfhout A.T., Rajamanickam S., Jensik P.J., Vergult S., Rocker N., Newhall K.J., Raghavan R., Reardon S.N., Jarrett K., McIntyre T., et al. Mutations affecting the SAND domain of DEAF1 cause intellectual disability with severe speech impairment and behavioral problems. Am. J. Hum. Genet. 2014;94:649–661. doi: 10.1016/j.ajhg.2014.03.013. - DOI - PMC - PubMed
    1. Vulto-Van Silfhout-De Vries Syndrome VSVS (Online Resource) [(accessed on 26 May 2020)]. Available online: https://www.omim.org/entry/615828.
    1. Rajab A., Schuelke M., Gill E., Zwirner A., Seifert F., Gonzalez S., Knierimet E. Recessive DEAF1 mutation associates with autism, intellectual disability, basal ganglia dysfunction and epilepsy. J. Med. Genet. 2015;52:607–611. doi: 10.1136/jmedgenet-2015-103083. - DOI - PubMed
    1. Maria J., Nabais S. De novo and biallelic DEAF1 variants cause a phenotypic spectrum. Genet. Med. 2019;21:2059–2069. doi: 10.1038/s41436-019-0473-6. - DOI - PubMed

Publication types